Stocks
GlaxoSmithKline (GSK) P/BV US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | -5.52 | -6.57 | -13.1 | 23.3 | -18.2 | -15.8 | ||
| Changes by years, y/y, % | +60% | +19% | +100% | -277% | -178% | +35.2% | |||
GlaxoSmithKline. P/BV
GlaxoSmithKline. P/BV, changes, %
GlaxoSmithKline (GSK) P/BV US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/BV | ? | -15.1 | -16.1 | 23.3 | -18.3 | -19.8 | -15.8 | |
| Changes by years, y/y, % | -84% | +270% | -277% | +39% | +27% | |||
| Changes by quarters, q/q, % | +60% | +6% | -245% | -178% | +8% | |||
